Dependent variables | |||||||||
---|---|---|---|---|---|---|---|---|---|
fVAS | FSS | SF-36vsa | |||||||
B | R2 | p-value | B | R2 | p-value | B | R2 | p-value | |
Age, years | − 0.37 | 0.05 | 0.11 | − 0.02 | 0.02 | 0.36 | − 0.02 | 0 | 0.94 |
SES-CD | 0.56 | 0.03 | 0.20 | 0.06 | 0.06 | 0.07 | 1.21 | 0.17 | 0.001 |
HBI (n = 55) | 2.04 | 0.09 | 0.02 | 0.19 | 0.16 | 0.002 | 2.31 | 0.15 | 0.004 |
CRP, mg/L | 0.20 | 0.07 | 0.06 | 0.01 | 0.02 | 0.29 | 0.25 | 0.12 | 0.009 |
F-calprotectin, mg/kg (n = 52) | 0.00 | 0.02 | 0.30 | 0.00 | 0.07 | 0.06 | 0.09 | 0.09 | 0.036 |
SF-36bp scoresa | 0.54 | 0.28 | < 0.001 | 0.04 | 0.33 | < 0.001 | 0.50 | 0.29 | < 0.001 |
HADS-D (n = 55) | 3.26 | 0.19 | < 0.001 | 0.29 | 0.30 | < 0.001 | 3.57 | 0.29 | < 0.001 |
IL-1RA, pg/mL | 0.02 | 0.03 | 0.17 | 0.00 | 0.01 | 0.62 | 0.03 | 0.14 | 0.005 |
sIL-1RII, ng/mL | 0.00 | 0.02 | 0.37 | 0.00 | 0.00 | 0.91 | 0.00 | 0.00 | 0.77 |
HSP90α, ng/mL (n = 52) | 0.73 | 0.10 | 0.03 | 0.02 | 0.01 | 0.45 | 0.45 | 0.05 | 0.13 |
HMGB1, ng/mL (n = 52) | 8.84 | 0.06 | 0.08 | 0.84 | 0.11 | 0.02 | 5.24 | 0.03 | 0.24 |
Anti-frHMGB1 absb (n = 49) | − 41.66 | 0.20 | 0.001 | − 2.43 | 0.14 | 0.01 | − 26.02 | 0.10 | 0.03 |
PEDF, ng/mL (n = 46) | 0.01 | 0.00 | 0.73 | − 0.00 | 0.01 | 0.55 | 0.04 | 0.06 | 0.12 |
HPX, ng/mL (n = 46) | 0.02 | 0.02 | 0.36 | 0.00 | 0.04 | 0.18 | 0.03 | 0.11 | 0.027 |